Drugs / Lactobacillus acidophilus KS400
last change 10 days ago re-read 9 days ago

Lactobacillus acidophilus KS400

Developed for
bacterial vaginosis
Investigated by
Queen Savang Vadhana Memorial Hospital, Thailand

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT07344064 Feb → Jul 2026 overdue bacterial vaginosis Queen Savang Vadhana Memorial Hospital, Thailand Not yet recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Lactobacillus acidophilus KS400 “Gynoflor® vaginal tablets (containing Lactobacillus acidophilus KS400 and 0.03 mg estriol)” NCT07344064 ↗
Route Other “1 tablet inserted vaginally at bedtime for 6 consecutive days” NCT07344064 ↗